Evidence map›Paper›PMID 31642939›Full record

ReviewCellular and molecular life sciences : CMLS2020

The regulatory role of Myomaker and Myomixer-Myomerger-Minion in muscle development and regeneration.

Bide Chen, Wenjing You, Yizhen Wang, Tizhong Shan

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. A Brief Introduction into the Biological Phenomenon of Cell-Cell Fusion.Advances in experimental medicine and biology · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Exploring the Regulation ofJournal of developmental biology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Bide ChenCollege of Animal Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, China.
Wenjing YouCollege of Animal Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, China.
Yizhen WangCollege of Animal Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, China.
Tizhong ShanCollege of Animal Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, China. tzshan@zju.edu.cn.ORCID http://orcid.org/0000-0002-4738-414X
Ministry of Education of the People's Republic of China · CNFeed Control (Norway) · NO

Funding

National Natural Science Foundation of China 31672427National Natural Science Foundation of China 31722053
6 · The paper itself

Abstract

Skeletal muscle plays essential roles in motor function, energy, and glucose metabolism. Skeletal muscle formation occurs through a process called myogenesis, in which a crucial step is the fusion of mononucleated myoblasts to form multinucleated myofibers. The myoblast/myocyte fusion is triggered and coordinated in a muscle-specific way that is essential for muscle development and post-natal muscle regeneration. Many molecules and proteins have been found and demonstrated to have the capacity to regulate the fusion of myoblast/myocytes. Interestingly, two newly discovered muscle-specific membrane proteins, Myomaker and Myomixer (also called Myomerger and Minion), have been identified as fusogenic regulators in vertebrates. Both Myomaker and Myomixer-Myomerger-Minion have the capacity to directly control the myogenic fusion process. Here, we review and discuss the latest studies related to these two proteins, including the discovery, structure, expression pattern, functions, and regulation of Myomaker and Myomixer-Myomerger-Minion. We also emphasize and discuss the interaction between Myomaker and Myomixer-Myomerger-Minion, as well as their cooperative regulatory roles in cell-cell fusion. Moreover, we highlight the areas for exploration of Myomaker and Myomixer-Myomerger-Minion in future studies and consider their potential application to control cell fusion for cell-therapy purposes.

Indexed as

Muscle DevelopmentRegenerationAmino Acid SequenceAnimalsCell FusionGene Expression RegulationHumansMembrane ProteinsMuscle ProteinsMuscle, SkeletalMyoblasts, SkeletalSequence AlignmentMembrane ProteinsMuscle ProteinsMYMK protein, humanMYMX protein, humanMyoblast fusionMyogenesisMyomakerMyomixer–Myomerger–MinionMyotubeSkeletal muscle

Identifiers

PMID31642939
PMCPMC11105057
OpenAlexW2981389445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.